Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 12 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

2 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
4(57.1%)
Phase 2
1(14.3%)
Phase 4
1(14.3%)
Phase 3
1(14.3%)
7Total
N/A(4)
Phase 2(1)
Phase 4(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (12)

Showing 12 of 12 trials
NCT07406867Recruiting

Diagnostic Accuracy of Oral Images, OPGs, Biomarkers and Questionnaires vs. Clinical Assessment for Periodontal Disease (PostNCT07164573)

Role: collaborator

NCT07164573Not Yet Recruiting

Diagnostic Accuracy of Oral Images, OPGs, and Questionnaires vs. Clinical Assessment for Periodontal Disease

Role: collaborator

NCT06296277Not Yet Recruiting

Mechanical Ventilation in Surgical Patients

Role: collaborator

NCT03766321Not ApplicableActive Not Recruiting

Fecal Microbiota Transplantation Effect on Amyotrophic Lateral Sclerosis Patients

Role: collaborator

NCT04744922Not ApplicableCompleted

Clinical and Biological Effects of Citrus-phytochemicals in Subjective Cognitive Decline.

Role: collaborator

NCT04169750Not ApplicableUnknown

Home-based EXergames To impRove cognitivE Function in MUltiple Sclerosis

Role: collaborator

NCT03018535Phase 3Unknown

Rituximab Versus Steroids and Cyclophosphamide in the Treatment of Idiopathic Membranous Nephropathy

Role: collaborator

NCT02464475Not ApplicableCompleted

Effects of OMT on Interoception

Role: collaborator

NCT03577015Unknown

International Prospective Registry of Disseminated Intravascular Coagulation

Role: collaborator

NCT01762826Unknown

Myo-inositol, D-chiro-inositol, and D-chiro/Myo-inositol in Gestational Diabetes

Role: collaborator

NCT01466452Phase 2Unknown

Antiplatelet Effect of Low Doses of Aspirin Taken Every 12 Hours in Patients Undergoing Coronary Artery Bypass Graft and/or Aortic Valve Surgery

Role: collaborator

NCT00565500Phase 4Completed

Celecoxib, Ibuprofen and the Antiplatelet Effect of Aspirin

Role: lead

All 12 trials loaded